In a collaboration with Vitafoods Insights, our Head of clinical research, Felix Alt, wrote an article about the impact of COVID-19 on clinical research in consumer healthcare, where he talks about the challenges and disruptions clinical research organizations (CROs) suffered during the coronavirus pandemic and how CROs are adjusting to the situation providing mid- and long-term perspectives. To read the full article, please visit Vitafoods Insights by clicking here.

Interestingly, an increasing demand for clinical research is being observed as a result of the pandemic. This is being driven by consumers’ demand for products that provide certain health benefits. Thus, clinical research is essential for the scientific substantiation of product claims as well as supporting consumers’ brand trust and education.